Apr 16 2019 0 Motif Bio Presents New Iclaprim Data at ECCMID 2019 https://www.motifbio.com/wp-content/uploads/2019/04/20190416_MTFB_PR_ECCMID-data.pdf
Apr 15 2019 0 Motif Bio Reports Fiscal Year 2018 Results https://www.motifbio.com/wp-content/uploads/2019/04/MTFB-Year-End-Financial-Results-RNS-15.04.19.pdf
Apr 04 2019 0 Motif Bio to Present Iclaprim Data at ECCMID 2019 https://www.motifbio.com/wp-content/uploads/2019/04/20190404_MTFB_PR_ECCMID-Curtain-raiser_FINAL.pdf
Apr 02 2019 0 Holding(s) in Company https://www.motifbio.com/wp-content/uploads/2019/04/MTFB-TR-1-HSBC-Bank-plc-02.04.19.pdf
Apr 01 2019 0 Holding(s) in Company https://www.motifbio.com/wp-content/uploads/2019/04/MTFB-TR-1-SAND-GROVE-CAPITAL-MANAGEMENT-LLP-01.04.19.pdf
Apr 01 2019 0 Holding(s) in Company https://www.motifbio.com/wp-content/uploads/2019/04/Motif-Bio-Plc-01042019-1-april.pdf
Mar 26 2019 0 Motif Bio Raises £2.7m (US$3.55m) https://www.motifbio.com/wp-content/uploads/2019/03/MTFB-Motif-Bio-Raises-£2.7m-US3.55m-26.03.19.pdf
Mar 25 2019 0 Proposed Equity Fundraise https://www.motifbio.com/wp-content/uploads/2019/03/MTFB-Proposed-Equity-Fundraise-25.03.19.pdf
Mar 20 2019 0 Motif Bio Granted Meeting with U.S. FDA regarding Iclaprim https://www.motifbio.com/wp-content/uploads/2019/03/20190320_PR-MTFB-FDA-meeting-granted.pdf
Mar 20 2019 0 Holding(s) in Company https://www.motifbio.com/wp-content/uploads/2019/03/Notifications-of-Major-Interest.pdf
